Abilify and Allergic rhinitis - a phase IV clinical study of FDA data
Summary:
Allergic rhinitis is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Ambien, and have Metastases to bone.
The phase IV clinical study analyzes which people have Allergic rhinitis when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.
What is Allergic rhinitis?
Allergic rhinitis is found to be associated with 909 drugs and 1,317 conditions by eHealthMe. Check the latest studies of Allergic rhinitis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
97,308 people reported to have side effects when taking Abilify.
Among them, 41 people (0.04%) have Allergic rhinitis.

Among these 41 people:
How long have people been on Abilify when they have Allergic rhinitis? *
- < 1 month: 14.29 %
- 1 - 6 months: 28.57 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 14.29 %
- 2 - 5 years: 14.29 %
- 5 - 10 years: 14.29 %
- 10+ years: 14.29 %
What is the gender of people who have Allergic rhinitis when taking Abilify? *
- female: 80 %
- male: 20 %
What is the age of people who have Allergic rhinitis when taking Abilify? *
- 0-1: 0.0 %
- 2-9: 2.94 %
- 10-19: 0.0 %
- 20-29: 5.88 %
- 30-39: 17.65 %
- 40-49: 20.59 %
- 50-59: 20.59 %
- 60+: 32.35 %
What are other drugs people take besides Abilify? *
- Ambien: 16 people, 39.02%
- Zometa: 14 people, 34.15%
- Percocet: 14 people, 34.15%
- Zoloft: 13 people, 31.71%
- Restoril: 13 people, 31.71%
- Xanax: 13 people, 31.71%
- Oxycontin: 12 people, 29.27%
- Aredia: 11 people, 26.83%
- Lasix: 11 people, 26.83%
- Cefazolin: 11 people, 26.83%
What are other side effects people have besides Allergic rhinitis? *
- Back Pain: 22 people, 53.66%
- Pain In Extremity: 19 people, 46.34%
- Abdominal Pain: 18 people, 43.90%
- Stress And Anxiety: 18 people, 43.90%
- Urinary Tract Infection: 18 people, 43.90%
- Rashes (redness): 17 people, 41.46%
- Cellulitis (infection under the skin): 17 people, 41.46%
- Pain: 17 people, 41.46%
- Injury: 15 people, 36.59%
- Fall: 14 people, 34.15%
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 14 people, 34.15%
- Stress And Anxiety: 12 people, 29.27%
- Breast Cancer: 11 people, 26.83%
- Osteoporosis (bones weak and more likely to break): 7 people, 17.07%
- Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 7 people, 17.07%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 7 people, 17.07%
- Insomnia (sleeplessness): 6 people, 14.63%
- Sleep Disorder: 5 people, 12.20%
- Pain: 5 people, 12.20%
- Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 7.32%
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Allergic rhinitis?
- Check whether Allergic rhinitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abilify:
- Abilify (101,455 reports)
Allergic rhinitis treatments and more:
- Allergic rhinitis (20,443 reports)
How severe was Allergic rhinitis and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Allergic rhinitis:
- Allergic rhinitis (909 drugs)
Browse all the conditions that are associated with Allergic rhinitis:
- Allergic rhinitis (1,317 conditions)
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Simvastatin and Alogliptin - 6 seconds ago
- Lyrica and Nosebleed for Women aged 40-49 - 13 seconds ago
- Lyrica and Nose Bleeds for Women aged 40-49 - 13 seconds ago
- Lyrica and Nosebleeds for Women aged 40-49 - 14 seconds ago
- Lyrica and Epistaxis for Women aged 40-49 - 14 seconds ago
- Lyrica and Bleeding From The Nose for Women aged 40-49 - 14 seconds ago
- Lyrica and Nose Bleed for Women aged 40-49 - 15 seconds ago
- Temazepam and Speech Impairment (Adult) for Women aged 30-39 - 28 seconds ago
- Temazepam and Slurred Speech for Women aged 30-39 - 29 seconds ago
- Temazepam and Language Impairment for Women aged 30-39 - 29 seconds ago